PHP
MNTA

Parkman Healthcare Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Parkman Healthcare Partners’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-175,453
Closed -$4.77M – 89
2020
Q1 		$4.77M Buy
+175,453
New +$4.88M 2.21% 12

Other funds holding MNTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Parkman Healthcare Partners's MNTA Position: Q2 2020 in Review

Parkman Healthcare Partners sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2020, closing a stake of 175,453 shares — an estimated $4.77M sold.

Parkman Healthcare Partners first reported a position in MNTA in Q1 2020 and held it in 1 quarter. The position peaked at $4.77M in Q1 2020. 237 funds tracked by Wall St. Rank hold MNTA as of Q2 2020.

  • Parkman Healthcare Partners reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Parkman Healthcare Partners sold 175,453 Momenta Pharmaceuticals, Inc. shares in Q2 2020, an estimated $4.77M.
  • Parkman Healthcare Partners first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2020 and held it in 1 quarter.
  • Parkman Healthcare Partners's Momenta Pharmaceuticals, Inc. position peaked at $4.77M in Q1 2020.
  • 237 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2020.

Based on Parkman Healthcare Partners's 13F filing for Q2 2020, filed 13 Aug 2020.